Zentek Announces Upsizing of Non-Brokered Private Placement to up to $2,500,000

Core Points - Zentek Ltd. has announced an increase in its non-brokered private placement to a total of up to $2,500,000, allowing for the issuance of up to 2,358,490 Units at a price of $1.06 per Unit [1] - The proceeds from the Offering will be utilized for working capital and general corporate purposes [1] Summary by Sections Offering Details - Each Unit consists of one Common Share, one-half of a Series A Warrant, and one-half of a Series B Warrant [2] - Series A Warrants allow the purchase of one Common Share at $1.50 for 24 months, with potential acceleration if the share price reaches $2.00 for 10 consecutive trading days [3] - Series B Warrants allow the purchase of one Common Share at $2.00 for 36 months, with potential acceleration if the share price reaches $3.00 for 10 consecutive trading days [4] Regulatory and Compliance - The closing of the Offering is subject to necessary corporate and regulatory approvals, including TSXV approval [5] - All securities issued will be subject to a hold period of four months plus a day from the date of issuance [5] Company Overview - Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development, and commercialization of innovative products [7] - The company's patented technology platform, ZenGUARD™, enhances viral filtration efficiency for surgical masks and HVAC systems [8] - Zentek holds a global exclusive license to an Aptamer-based platform technology developed by McMaster University for diagnostic and therapeutic markets [10]